explore -WSS

explore

author：explore 2025-10-01 23:06:36 - browse：19

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： When is a doctor not a doctor? Try when patients address women doctors

focus

WSS

IRA could hurt research into orphan drugs for rare diseases

Long Covid needs a new name — and a new frame

Inside the fall of star MIT scientist David Sabatini

PEPFAR is under serious threat — and so is global health

Australia's humpback populations rebound raising hopes of marine scientists

Make 'food is medicine' a key part of White House nutrition meeting

entertainment

explore

Wikipedia

Hollywood unions extend contract negotiations for actors

Grail is spending more than ever lobbying Congress

Moonlake's readout produced a cash windfall. Risks remain

PEPFAR is under serious threat — and so is global health

ChatGPT in medicine: STAT answers readers' burning questions

Grail is spending more than ever lobbying Congress

At least 13 dead in Texas as scorching temps continue

4th of July breaks record for highest global temperature ever measured

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How medical schools plan to diversify without affirmative action

Wikipedia

These geoengineering technologies could help combat the climate crisis, scientists say

Did the public have the right to know Arthur Ashe had AIDS?

Listen: PBM conflicts, RSV vaccines, & the future of flu season

IRA could hurt research into orphan drugs for rare diseases

Generate Biomedicines machine learning biotech raises $273M

IRA could hurt research into orphan drugs for rare diseases

focus

explore

hotspot

hotspot